Forventes på lager: 31-03-2020
Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes.
| Forlag | Jaypee Brothers Medical Publishers |
| Forfattere | Rajeev Chawla, Shalini Jaggi |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgivelsesdato | 31-03-2020 |
| Første udgivelsesår | 2020 |
| Illustrationer | 15 Illustrations |
| Originalsprog | India |
| Sideantal | 114 |
| Indbinding | Paperback / softback |
| Forlag | Jaypee Brothers Medical Publishers |
| Sideoplysninger | 114 pages, 15 Illustrations |
| Mål | 140 x 215 x 8 |
| ISBN-13 / EAN-13 | 9789352706808 |